Top compounds associated with response to TIMM8B


Feature Type Standardized
Nominal ANOVA
mRNA CD-437 CTRPv2 pan-cancer AAC -0.077 0.02
mRNA barasertib CTRPv2 pan-cancer AAC -0.077 0.02
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.02
mRNA Crizotinib CCLE pan-cancer AAC -0.11 0.02
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.072 0.02
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.072 0.02
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.066 0.02
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA tivozanib CTRPv2 pan-cancer AAC -0.086 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
Download CSV